Literature DB >> 20106900

International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Therese Truong1, Wiebke Sauter, James D McKay, H Dean Hosgood, Carla Gallagher, Christopher I Amos, Margaret Spitz, Joshua Muscat, Philip Lazarus, Thomas Illig, H Erich Wichmann, Heike Bickeböller, Angela Risch, Hendrik Dienemann, Zuo-Feng Zhang, Behnaz Pezeshki Naeim, Ping Yang, Shanbeh Zienolddiny, Aage Haugen, Loïc Le Marchand, Yun-Chul Hong, Jin Hee Kim, Eric J Duell, Angeline S Andrew, Chikako Kiyohara, Hongbing Shen, Keitaro Matsuo, Takeshi Suzuki, Adeline Seow, Daniel P K Ng, Qing Lan, David Zaridze, Neonilia Szeszenia-Dabrowska, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Vali Constantinescu, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Neil E Caporaso, Demetrius Albanes, Michael Thun, Maria Teresa Landi, Joanna Trubicka, Marcin Lener, Jan Lubinski, Ying Wang, Amélie Chabrier, Paolo Boffetta, Paul Brennan, Rayjean J Hung.   

Abstract

BACKGROUND: Analysis of candidate genes in individual studies has had only limited success in identifying particular gene variants that are conclusively associated with lung cancer risk. In the International Lung Cancer Consortium (ILCCO), we conducted a coordinated genotyping study of 10 common variants selected because of their prior evidence of an association with lung cancer. These variants belonged to candidate genes from different cancer-related pathways including inflammation (IL1B), folate metabolism (MTHFR), regulatory function (AKAP9 and CAMKK1), cell adhesion (SEZL6) and apoptosis (FAS, FASL, TP53, TP53BP1 and BAT3).
METHODS: Genotype data from 15 ILCCO case-control studies were available for a total of 8431 lung cancer cases and 11 072 controls of European descent and Asian ethnic groups. Unconditional logistic regression was used to model the association between each variant and lung cancer risk.
RESULTS: Only the association between a non-synonymous variant of TP53BP1 (rs560191) and lung cancer risk was significant (OR = 0.91, P = 0.002). This association was more striking for squamous cell carcinoma (OR = 0.86, P = 6 x 10(-4)). No heterogeneity by center, ethnicity, smoking status, age group or sex was observed. In order to confirm this association, we included results for this variant from a set of independent studies (9966 cases/11,722 controls) and we reported similar results. When combining all these studies together, we reported an overall OR = 0.93 (0.89-0.97) (P = 0.001). This association was significant only for squamous cell carcinoma [OR = 0.89 (0.85-0.95), P = 1 x 10(-4)].
CONCLUSION: This study suggests that rs560191 is associated to lung cancer risk and further highlights the value of consortia in replicating or refuting published genetic associations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106900      PMCID: PMC2847090          DOI: 10.1093/carcin/bgq001

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  55 in total

1.  Indoor coal combustion emissions, GSTM1 and GSTT1 genotypes, and lung cancer risk: a case-control study in Xuan Wei, China.

Authors:  Q Lan; X He; D J Costa; L Tian; N Rothman; G Hu; J L Mumford
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-06       Impact factor: 4.254

2.  The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.

Authors:  Eugenia E Calle; Carmen Rodriguez; Eric J Jacobs; M Lyn Almon; Ann Chao; Marjorie L McCullough; Heather S Feigelson; Michael J Thun
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

3.  Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study.

Authors:  H Shen; M R Spitz; L E Wang; W K Hong; Q Wei
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-04       Impact factor: 4.254

4.  p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.

Authors:  Xifeng Wu; Hua Zhao; Christopher I Amos; Sanjay Shete; Nimisha Makan; Waun K Hong; Fred F Kadlubar; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

5.  A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

Authors:  Maria Teresa Landi; Nilanjan Chatterjee; Kai Yu; Lynn R Goldin; Alisa M Goldstein; Melissa Rotunno; Lisa Mirabello; Kevin Jacobs; William Wheeler; Meredith Yeager; Andrew W Bergen; Qizhai Li; Dario Consonni; Angela C Pesatori; Sholom Wacholder; Michael Thun; Ryan Diver; Martin Oken; Jarmo Virtamo; Demetrius Albanes; Zhaoming Wang; Laurie Burdette; Kimberly F Doheny; Elizabeth W Pugh; Cathy Laurie; Paul Brennan; Rayjean Hung; Valerie Gaborieau; James D McKay; Mark Lathrop; John McLaughlin; Ying Wang; Ming-Sound Tsao; Margaret R Spitz; Yufei Wang; Hans Krokan; Lars Vatten; Frank Skorpen; Egil Arnesen; Simone Benhamou; Christine Bouchard; Andres Metspalu; Andres Metsapalu; Tonu Vooder; Mari Nelis; Kristian Välk; John K Field; Chu Chen; Gary Goodman; Patrick Sulem; Gudmar Thorleifsson; Thorunn Rafnar; Timothy Eisen; Wiebke Sauter; Albert Rosenberger; Heike Bickeböller; Angela Risch; Jenny Chang-Claude; H Erich Wichmann; Kari Stefansson; Richard Houlston; Christopher I Amos; Joseph F Fraumeni; Sharon A Savage; Pier Alberto Bertazzi; Margaret A Tucker; Stephen Chanock; Neil E Caporaso
Journal:  Am J Hum Genet       Date:  2009-10-15       Impact factor: 11.025

6.  Attributable risks of familial cancer from the Family-Cancer Database.

Authors:  Kari Hemminki; Kamila Czene
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

7.  European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection.

Authors:  E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci
Journal:  Public Health Nutr       Date:  2002-12       Impact factor: 4.022

8.  A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.

Authors:  Nina E Landvik; Kent Hart; Vidar Skaug; Lodve B Stangeland; Aage Haugen; Shanbeh Zienolddiny
Journal:  Carcinogenesis       Date:  2009-05-21       Impact factor: 4.944

9.  Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways.

Authors:  I Rappold; K Iwabuchi; T Date; J Chen
Journal:  J Cell Biol       Date:  2001-04-30       Impact factor: 10.539

10.  Lung cancer in a U.S. population with low to moderate arsenic exposure.

Authors:  Julia E Heck; Angeline S Andrew; Tracy Onega; James R Rigas; Brian P Jackson; Margaret R Karagas; Eric J Duell
Journal:  Environ Health Perspect       Date:  2009-07-02       Impact factor: 9.031

View more
  33 in total

1.  Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Authors:  Jie Lin; Charles Lu; David J Stewart; Jian Gu; Maosheng Huang; David W Chang; Scott M Lippman; Xifeng Wu
Journal:  Carcinogenesis       Date:  2012-06-04       Impact factor: 4.944

2.  Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.

Authors:  Darren R Brenner; Christopher I Amos; Yonathan Brhane; Maria N Timofeeva; Neil Caporaso; Yufei Wang; David C Christiani; Heike Bickeböller; Ping Yang; Demetrius Albanes; Victoria L Stevens; Susan Gapstur; James McKay; Paolo Boffetta; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Frank Skorpen; Maiken E Gabrielsen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Peter Broderick; Timothy Eisen; Xifeng Wu; Di Zhang; Wei Chen; Margaret R Spitz; Yongyue Wei; Li Su; Dong Xie; Jun She; Keitaro Matsuo; Fumihiko Matsuda; Hidemi Ito; Angela Risch; Joachim Heinrich; Albert Rosenberger; Thomas Muley; Hendrik Dienemann; John K Field; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Michael P A Davies; Michael Marcus; John McLaughlin; Irene Orlow; Younghun Han; Yafang Li; Xuchen Zong; Mattias Johansson; Geoffrey Liu; Shelley S Tworoger; Loic Le Marchand; Brian E Henderson; Lynne R Wilkens; Juncheng Dai; Hongbing Shen; Richard S Houlston; Maria T Landi; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2015-09-10       Impact factor: 4.944

3.  Polymorphism rs7214723 in CAMKK1 and lung cancer risk in Chinese population.

Authors:  Yan-Hong Zhang; Qing Xu; Zhenhong Zhao; Junjie Wu; Wei-Xing Liu; Hui Wang; Li Jin; Jiu-Cun Wang
Journal:  Tumour Biol       Date:  2013-06-05

4.  Genome-wide significant association between a sequence variant at 15q15.2 and lung cancer risk.

Authors:  Thorunn Rafnar; Patrick Sulem; Soren Besenbacher; Daniel F Gudbjartsson; Carlo Zanon; Julius Gudmundsson; Simon N Stacey; Jelena P Kostic; Thorgeir E Thorgeirsson; Gudmar Thorleifsson; Hjordis Bjarnason; Halla Skuladottir; Tomas Gudbjartsson; Helgi J Isaksson; Dolores Isla; Laura Murillo; Maria D García-Prats; Angeles Panadero; Katja K H Aben; Sita H Vermeulen; Henricus F M van der Heijden; William J Feser; York E Miller; Paul A Bunn; Augustine Kong; Holly J Wolf; Wilbur A Franklin; Jose I Mayordomo; Lambertus A Kiemeney; Steinn Jonsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

5.  BAT3 rs1052486 and rs3117582 polymorphisms are associated with lung cancer risk: a meta-analysis.

Authors:  Jiquan Chen; Yuan-Sheng Zang; Qingyu Xiu
Journal:  Tumour Biol       Date:  2014-07-04

6.  MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.

Authors:  Min-Hui Yang; Zhi-Yan Hu; Chuan Xu; Lin-Ying Xie; Xiao-Yan Wang; Shi-You Chen; Zu-Guo Li
Journal:  Biochim Biophys Acta       Date:  2014-11-18

7.  Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer.

Authors:  Sungshim L Park; Steven G Carmella; Xun Ming; Elizabeth Vielguth; Daniel O Stram; Loic Le Marchand; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-26       Impact factor: 4.254

Review 8.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

9.  Heme-related gene expression signatures of meat intakes in lung cancer tissues.

Authors:  Tram Kim Lam; Melissa Rotunno; Brid M Ryan; Angela C Pesatori; Pier Alberto Bertazzi; Margaret Spitz; Neil E Caporaso; Maria Teresa Landi
Journal:  Mol Carcinog       Date:  2013-05-16       Impact factor: 4.784

10.  AKAP-9 promotes colorectal cancer development by regulating Cdc42 interacting protein 4.

Authors:  Zhi-Yan Hu; Yan-Ping Liu; Lin-Ying Xie; Xiao-Yan Wang; Fang Yang; Shi-You Chen; Zu-Guo Li
Journal:  Biochim Biophys Acta       Date:  2016-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.